OneMedNet Corp Annual Report: A Simple Breakdown

I’ve put together this guide to help you understand how OneMedNet Corp performed this year. My goal is to turn complex financial filings into plain English so you can decide if this company fits your investment goals.

1. What does this company do?

OneMedNet works in healthcare data. They curate and de-identify medical images and clinical records, acting as a bridge between healthcare providers and researchers.

They make money in two ways:

• Subscriptions: Recurring access to their "iRWD" data platform.
• Data delivery: One-off projects for pharmaceutical and medical device companies.

The company reported $10.4 million in annual revenue. They are currently shifting from one-time projects to a more reliable, subscription-based model.

2. Financial Performance & Health

OneMedNet is in a "heavy lifting" phase. They are building their network but aren't yet making enough cash to cover their costs. They reported a loss of about $18.5 million this year.

• The Funding Treadmill: The company relies heavily on complex financing. Throughout 2024 and 2025, they used stock purchase agreements, convertible notes, and warrants to raise cash. They typically keep only $2.5 million to $3.0 million in the bank—barely enough to cover a few months of expenses.
• What this means for you: When a company constantly issues new shares to stay afloat, it causes "dilution." Think of this like slicing a pizza into more pieces; even if the pizza stays the same size, your slice gets smaller. OneMedNet has significantly increased its total share count, which reduces the potential value for existing shareholders.

3. Major Wins and Challenges

• Complex Financial Engineering: The company manages a web of debt and warrants. Some agreements allow the conversion price of debt into stock to drop if the share price falls. This can lead to rapid, aggressive dilution during market downturns.
• Asset Volatility: The company holds about $0.5 million in Bitcoin. This is unusual for a healthcare data firm. It adds unnecessary risk and makes their quarterly earnings harder to predict.
• Operational Costs: They spent over $15 million on general and administrative costs. While they are spending aggressively to grow, their profit margins (40-50%) aren't yet high enough to cover these heavy operating expenses.

4. Key Risks

• Dilution: Because they fund operations by selling stock, the number of shares keeps growing. This can create a cycle where issuing shares to pay debt lowers the stock price, forcing them to issue even more shares to raise the same amount of money.
• Debt & Obligations: They juggle various types of debt and warrants. Changes in the stock price cause the accounting value of these liabilities to swing wildly, which can hide the company's true performance.
• Customer Concentration: Their top three customers provide over 50% of their revenue. Losing just one major partner would cause a significant drop in total sales.

5. Future Outlook

OneMedNet is in a race to grow revenue before their financing options become too expensive. They are working to onboard more healthcare providers to increase high-margin subscription sales. Currently, their main "product" is managing their own survival through constant fundraising. Their success depends on becoming cash-flow positive before they run out of ways to raise capital.

Investor Checklist: Before you decide on OneMedNet, ask yourself:

1. Am I comfortable with dilution? If the company continues to issue shares to fund operations, your ownership percentage will likely decrease.
2. Can they reach profitability? Look for future reports to see if their subscription revenue grows enough to cover their $15M+ in operating costs.
3. Is the risk profile right for me? Between the Bitcoin holdings and the complex debt structure, this is a high-risk, speculative play.

Note: This guide is for informational purposes and is not financial advice. Always do your own research before buying stock.